Tarsons Products Limited · NSE:TARSONS
Tarsons Products — Q3 FY2025 Earnings Presentation
31 slides from Tarsons Products's earnings presentation, Feb 15, 2025
Slide 1: Exchange filing cover letter for investor presentation
An ISO 9001 & ISO 13485 Certified Company Date: 15th February, 2025 To, To, BSE Limited (“BSE”), National Stock Exchange of India Limited (“NSE”) Corporate Relationship Department, “Exchange Plaza”, 5th Floor, 2nd Floor, New Trading Ring, Plot No. C/1, G Block, P.J. Towers, Dalal Street, Bandra-Kurl
Slide 2: Tarsons Products Limited Investor Presentation February 2025
TARSONS PRODUCTS LIMITED Investor Presentation February 2025 TRUST DELIVERED
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Tarsons Products Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secu
Slide 4: Q3 & 9MFY25 Financial Highlights
Q3 & 9MFY25 Financial Highlights
Slide 5: Q3FY25 Key Operational Highlights
Q3FY25 Key Operational Highlights Revenue (in Rs. Crs) Geography Mix Highest Ever Q3 Revenue Standalone Standalone Consolidated Standalone Standalone Consolidated +23% 96 76 25% 30% 62 53 14.3% 45% Q3FY24 Q3FY25 Q3FY25 53 55% 46 70% 75% 43 15 50.4% 23 Q3FY24 Q3FY25 Q3FY25 Domestic Overseas ➢ Consoli
Slide 6: 9MFY25 Key Operational Highlights
9MFY25 Key Operational Highlights Revenue (in Rs. Crs) Geography Mix Highest Ever 9M Revenue Standalone Standalone Consolidated Standalone Standalone Consolidated +16% 280 221 191 29% 33% 148 9.6% 47% 9MFY25 148 9MFY24 9MFY25 53% 135 71% 67% 132 55 31.6% 73 9MFY24 9MFY25 9MFY25 Domestic Overseas ➢ C
Slide 7: Q3FY25 Key Financial Highlights
Q3FY25 Key Financial Highlights Revenue (in Rs. crs) EBITDA (in Rs. crs) Profit After Tax (in Rs. crs) Cash PAT# (in Rs. crs) Standalone Standalone Consolidated Standalone Standalone Consolidated Standalone Standalone Consolidated Standalone Standalone Consolidated 95.7 29.6 10.1 23.2 27.9 22.7 20.1
Slide 8: 9MFY25 Key Financial Highlights
9MFY25 Key Financial Highlights Revenue (in Rs. crs) Adj. EBITDA*^ (in Rs. crs) Profit After Tax (in Rs. crs) Cash PAT# (in Rs. crs) Standalone Standalone Consolidated Standalone Standalone Consolidated Standalone Standalone Consolidated Standalone Standalone Consolidated 279.7 83.0 32.5 60.5 63.5 6
Slide 9: Bridge between Standalone & Consolidated PAT
Bridge between Standalone & Consolidated PAT (in Rs. crs) 27.0 2.4 19.6 -6.7 -0.7 -2.4 9MFY25 Interest Income & Interest paid to Amortisation on PAT of Nerbe 9MFY25 Standalone PAT Gurantee Commission Bank by Subsidiary intangible Consolidated PAT eliminated at assets acquired Consolidated levels 8
Slide 10: Management Commentary
Management Commentary Commenting on the performance of the company Mr. Aryan Sehgal, Promoter and Whole time Director of Tarsons, said: “We are pleased to announce that our standalone revenues increased by 23.3% y-o-y in Q3FY25 and by 16.0% y-o-y in 9MFY25. The sector has encountered several difficu
Slide 11: Q3 & 9MFY25 Profit & Loss Statement
Q3 & 9MFY25 Profit & Loss Statement Particulars (in Rs. Crs) Q3FY25 (Stand) Q3FY24 (Stand) YoY Q3FY25 (Consol) 9MFY25 (Stand) 9MFY24 (Stand) YoY 9MFY25 (Consol) Revenue from Operations 76.2 61.8 23.3% 95.7 221.1 190.7 16.0% 279.7 Cost of Goods Sold 21.9 16.7 31.2 62.9 49.0 91.6 Gross Profit 54.3 45.
Slide 12: About Tarsons
TRUST DELIVERED
Slide 13: Tarsons – at a Glance
Tarsons – at a Glance One of the leading Indian labware company engaged in the designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop equipment & instruments) Products used in laboratories across research organizations, academia institutes, pharm
Slide 14: Our Journey
Our Journey Established Product portfolio Commenced Pioneered the first fully manufacturing facility expansion & adding Established line for PCR production of Pipette robotic clean room expanding into depth in existing products in Jalan Tips, thereby creating a plant for manufacturing production of
Slide 15: Leading Indian Labware Supplier
Leading Indian Labware Supplier Trusted Brand for high quality Expertise in production of a wide range Ability to offer differentiated, user products in the plastic labware of labware products & amongst the friendly, reliable quality & cost-effective market with 40+ years vintage in the top 3 player
Slide 16: Our Competitive Edge
Our Competitive Edge Geographical Presence Brand & Quality Wide geographic reach through a Leading Indian supplier to the life sciences strong sales & distribution sector with strong brand recognition and network high-quality diversified products across varied customer segments. 03 04 State of Art F
Slide 17: Catering to diversified End User Industry
Catering to diversified End User Industry… Measures to strengthen customer relations Academic Institutes National Centre Indian Institute of Rain Forest KIIT Regular Feedback from Customers on quality, & Research for Biological Chemical Research Institute University 1 delivery & cost Sciences Techno
Slide 18: Our State-of-the-art Manufacturing Facilities
Our State-of-the-art Manufacturing Facilities… Key Highlights of the High Precision Manufacturing Process ✓ Vertically integrated manufacturing capabilities with design & development being carried out in-house ✓ Automated manufacturing with use of robotics & other technologies developed in collabora
Slide 19: Widespread Domestic Sales & Distribution network
…with widespread Domestic Sales & Distribution network… Comprehensive Pan-India Distribution Network Long-standing relationships with Distributors North: 15% of FY24 Domestic Sales East: 16% of FY24 Domestic Sales 43 Distributors 41 Distributors West: 24% of FY24 Domestic Sales 22 Distributors South
Slide 20: Huge underlying Export Market Potential
…with huge underlying Export Market Potential… Huge Export Opportunity Market One of the very few players to have a Global Reach ✓ As of 31st March 2024, the company sold its products to 40+ countries via 45+ distributors Demand for plasticware expected to grow at 10% CAGR for developing ✓ Export op
Slide 21: Wide Range of High-Quality Products
…offering Wide Range of High-Quality Products… Our products are made from high-quality medical grade DMF registered resins which are selected to minimize additives & reduce potential leachable Consumables Reusables Others 55% of FY24 40% of FY24 5% of FY24 Revenues Revenues Revenues • Portfolio of p
Slide 22: Diversified product portfolio of Plastic Labware
…diversified product portfolio of Plastic Labware Centrifuge Sterile Media Pipette Tips Petri Dishes Cryo Vials Storage Vials Serological Pipette Tubes Bottles Consumables (55% of FY24 Sales) • Mostly used in culture Designed for use Disposable pipettes Suited to preparation Used for storage of Perf
Slide 23: Glimpse of our product portfolio & processes
Glimpse of our product portfolio & processes Video link – Click here Video link – Click here Video link – Click here Video link – Click here Video link – Click here For more information & videos please visit www.tarsons.com/video-new 22
Slide 24: Key Business Strategies
Key Business Strategies • Focus on branding & promotion to enhance visibility in the labware industry to increase brand awareness & loyalty • Manufacture New Products in the cell culture & robotic handled consumables and expand Enhance existing & expand into the import dominated markets of these pro
Slide 25: Experienced Board of Director & Managerial Team
Experienced Board of Director & Managerial Team Suresh Prabhala Sanjive Sehgal Non-Executive Nominee Director Chairman & Managing Director • Currently acting as Co-founder & Managing Partner at ADV Partners • Chairman & Managing Director of Tarsons • Investment professional with 25+ years of experie
Slide 26: Contribution towards Environmental, Social & Governance
Contribution towards Environmental, Social & Governance Clean room conditions eliminates all chances of NO litigations faced for pollution or contamination Use of Medical Grade degradation of environment over the Plastics. Products are designed to past five years Productivity optimisation with use o
Slide 27: Industry Update
DELIVERING TRUST
Slide 28: Plastic Labware Market
Plastic Labware Market Indian plastic labware market is expected to grow at 16% CAGR from 2020- Split of Global Market Size of Plastic Labware (2020) 2025 Certrifuge ▪ Centrifuge & Liquid Handling Global Laboratory Equipment Indian Laboratory Equipment ware market dominate the Laboratory Market Size
Slide 29: Rapid Shift from Glassware to Plasticware in India
Rapid Shift from Glassware to Plasticware in India Indian Laboratory Equipment Market (Breakup of Glassware and Plasticware segments) INR 10.8 bn INR 11.3 bn INR 8.4 bn Key reasons for the shift: Market Size INR 7.5 bn INR 12.2 bn INR 25.8 bn ▪ Increased Applicability: Superior ability to handle rad
Slide 30: Key Takeaways
Key Takeaways Leading Indian manufacturer of Financial profile with Historical labware with an established brand strong EBITDA margins & high & focus on high-quality products ROCE Presence in an industry with Highly automated state-of-the-art double-digit growth potential and manufacturing facilitie
Slide 31: Thank You
Thank You Tarsons Products Limited Strategic Growth Advisors Private Limited CIN: L51109WB1983PLC036510 CIN: U74140MH2010PTC204285 Mr. Santosh Agarwal – Chief Financial Officer Mr. Sagar Shroff / Mr. Nishant Dudhoria santosh@tarsons.in sagar.shroff@sgapl.net / nishant.dudhoria@sgapl.net +91 98205 19